LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression

Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. However, the molecular mechanisms of CRC pathogenesis are not fully understood. In this study, we report the characterization of LYAR (Ly-1 antibody reactive clone) as a key regulator of the migration and invasio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yupeng, Liu, Ming, Li, Zhuchen, Wu, Xiao-Bin, Wang, Ying, Wang, Yadong, Nie, Min, Huang, Feifei, Ju, Junyi, Ma, Chi, Tan, Renxiang, Zen, Ke, Zhang, Chen-Yu, Fu, Keqin, Chen, Yu-Gen, Wang, Ming-Rong, Zhao, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741737/
https://www.ncbi.nlm.nih.gov/pubmed/26413750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741737/
https://www.ncbi.nlm.nih.gov/pubmed/26413750

Ejemplares similares